Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronan Flippot

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Nature Reviews. Urology|May 22, 2019
Long non-coding RNAs in genitourinary malignancies: a whole new worldRonan Flippot, Guillaume Beinse, Alice Boilève, et al.
Bulletin Du Cancer|November 21, 2015
[Nivolumab, a new hope in non-small cell lung cancer]Ronan Flippot, Vincent Fallet, Benjamin Besse, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2016
Oncogenic viruses: Lessons learned using next-generation sequencing technologiesRonan Flippot, Gabriel G Malouf, Xiaoping Su, et al.
Oncotarget|June 25, 2016
Cancer subtypes classification using long non-coding RNARonan Flippot, Gabriel G Malouf, Xiaoping Su, et al.
European Urology Focus|March 5, 2019
State of the Future: Translational Approaches in Renal Cell Carcinoma in the Immunotherapy EraZiad Bakouny, Ronan Flippot, David A Braun, et al.
Cancers|January 8, 2020
Sarcomatoid Dedifferentiation in Renal Cell Carcinoma: From Novel Molecular Insights to New Clinical OpportunitiesVéronique Debien, Jonathan Thouvenin, Véronique Lindner, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2023
Triplet Strategies in Metastatic Clear Cell Renal Cell Carcinoma: A Worthy Option in the First-Line Setting?Catherine C Fahey, Jeffrey W Shevach, Ronan Flippot, et al.
Critical Reviews in Oncology/Hematology|July 6, 2019
Major pitfalls of protein kinase inhibitors prescription: A review of their clinical pharmacology for daily usePaul Gougis, Lola-Jade Palmieri, Christian Funck-Brentano, et al.
Nature Reviews. Clinical Oncology|January 13, 2021
Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinomaDavid A Braun, Ziad Bakouny, Laure Hirsch, et al.
Oncotarget|December 21, 2020
Identification of international metastatic renal cell carcinoma database consortium (IMDC) intermediate-risk subgroups in patients with metastatic clear-cell renal cell carcinomaAnnalisa Guida, Gwénaël Le Teuff, Carolina Alves, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Nature Reviews. Urology|May 22, 2019
Long non-coding RNAs in genitourinary malignancies: a whole new worldRonan Flippot, Guillaume Beinse, Alice Boilève, et al.
Bulletin Du Cancer|November 21, 2015
[Nivolumab, a new hope in non-small cell lung cancer]Ronan Flippot, Vincent Fallet, Benjamin Besse, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2016
Oncogenic viruses: Lessons learned using next-generation sequencing technologiesRonan Flippot, Gabriel G Malouf, Xiaoping Su, et al.
Oncotarget|June 25, 2016
Cancer subtypes classification using long non-coding RNARonan Flippot, Gabriel G Malouf, Xiaoping Su, et al.
European Urology Focus|March 5, 2019
State of the Future: Translational Approaches in Renal Cell Carcinoma in the Immunotherapy EraZiad Bakouny, Ronan Flippot, David A Braun, et al.
Cancers|January 8, 2020
Sarcomatoid Dedifferentiation in Renal Cell Carcinoma: From Novel Molecular Insights to New Clinical OpportunitiesVéronique Debien, Jonathan Thouvenin, Véronique Lindner, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2023
Triplet Strategies in Metastatic Clear Cell Renal Cell Carcinoma: A Worthy Option in the First-Line Setting?Catherine C Fahey, Jeffrey W Shevach, Ronan Flippot, et al.
Critical Reviews in Oncology/Hematology|July 6, 2019
Major pitfalls of protein kinase inhibitors prescription: A review of their clinical pharmacology for daily usePaul Gougis, Lola-Jade Palmieri, Christian Funck-Brentano, et al.
Nature Reviews. Clinical Oncology|January 13, 2021
Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinomaDavid A Braun, Ziad Bakouny, Laure Hirsch, et al.
Oncotarget|December 21, 2020
Identification of international metastatic renal cell carcinoma database consortium (IMDC) intermediate-risk subgroups in patients with metastatic clear-cell renal cell carcinomaAnnalisa Guida, Gwénaël Le Teuff, Carolina Alves, et al.
Pageof 8